Baumal Caroline 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-01-17$29.96/sh−1,853$55,513→ 53,707.37 total - Award
Common Stock
2025-01-21+39,594→ 93,301.37 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
- [F2]This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.